The effects of position on the radiographic joint space in osteoarthritis of the hip.

PubWeight™: 1.16‹?› | Rank: Top 10%

🔗 View Article (PMID 9010875)

Published in Osteoarthritis Cartilage on January 01, 1997

Authors

T Conrozier1, M G Lequesne, A M Tron, P Mathieu, L Berdah, E Vignon

Author Affiliations

1: Rheumatology Unit, Hôpital Edouard Herriot, Lyon, France.

Articles citing this

Association of hip pain with radiographic evidence of hip osteoarthritis: diagnostic test study. BMJ (2015) 2.21

Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: a one year prospective study. Ann Rheum Dis (1998) 1.27

The faux profil (oblique view) of the hip in the standing position. Contribution to the evaluation of osteoarthritis of the adult hip. Ann Rheum Dis (1998) 1.24

Prevalence of hip osteoarthritis in Iceland. Ann Rheum Dis (1999) 1.19

Weightbearing anteroposterior pelvic radiographs are recommended in DDH assessment. Clin Orthop Relat Res (2008) 1.04

PROPOSAL FOR STANDARDIZATION OF RADIOGRAPHIC STUDIES ON THE HIP AND PELVIS. Rev Bras Ortop (2015) 0.94

Reproducibility and sensitivity to change of various methods to measure joint space width in osteoarthritis of the hip: a double reading of three different radiographic views taken with a three-year interval. Arthritis Res Ther (2005) 0.91

Osteoarthritis of the hip: agreement between joint space width measurements on standing and supine conventional radiographs. Ann Rheum Dis (1998) 0.86

OARSI Clinical Trials Recommendations: Hip imaging in clinical trials in osteoarthritis. Osteoarthritis Cartilage (2015) 0.84

Reliability of radiographic parameters in adults with hip dysplasia. Skeletal Radiol (2011) 0.84

Radiographic evaluation of osteoarthritis of the hip: an inter-observer study of 61 hips treated for late-detected developmental hip dislocation. Acta Orthop (2012) 0.84

Randomised, controlled trial of avocado-soybean unsaponifiable (Piascledine) effect on structure modification in hip osteoarthritis: the ERADIAS study. Ann Rheum Dis (2013) 0.82

Absence of radiographic progression of hip arthritis during infliximab treatment for ankylosing spondylitis. Clin Rheumatol (2013) 0.80

Radiographic joint space width in patients with Crowe Type-I dysplastic hips. Clin Orthop Relat Res (2008) 0.75

Symphysis pubis width and unaffected hip joint width in patients with slipped upper femoral epiphysis: widening compared with normal values. Skeletal Radiol (2009) 0.75

Articles by these authors

Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the Chondromodulating Effect of Diacerein in OA of the Hip. Arthritis Rheum (2001) 3.37

Comparison between transcatheter and surgical prosthetic valve implantation in patients with severe aortic stenosis and reduced left ventricular ejection fraction. Circulation (2010) 3.16

Image coding using wavelet transform. IEEE Trans Image Process (1992) 2.95

Perivalvular abscesses associated with endocarditis; clinical features and prognostic factors of overall survival in a series of 233 cases. Perivalvular Abscesses French Multicentre Study. Eur Heart J (1999) 2.90

Rapid detection of methicillin-resistant staphylococci from blood culture bottles by using a multiplex PCR assay. J Clin Microbiol (2002) 2.19

Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis (2001) 2.18

Release of cytochrome c and activation of pro-caspase-9 following lysosomal photodamage involves Bid cleavage. Cell Death Differ (2002) 2.13

Suppression of cell cycle progression by flavonoids: dependence on the aryl hydrocarbon receptor. Carcinogenesis (1999) 1.96

Q fever endocarditis in the south of France. J Infect Dis (1987) 1.74

Association between circulating oxidised low-density lipoprotein and fibrocalcific remodelling of the aortic valve in aortic stenosis. Heart (2007) 1.67

Evaluation of the Duke criteria versus the Beth Israel criteria for the diagnosis of infective endocarditis. Clin Infect Dis (1995) 1.65

Radiological progression of hip osteoarthritis: definition, risk factors and correlations with clinical status. Ann Rheum Dis (1996) 1.64

Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicentre clinical trial using quantitative MRI. Ann Rheum Dis (2008) 1.62

Phospholipase A2 activity in herniated lumbar discs. Clinical correlations and inhibition by piroxicam. Spine (Phila Pa 1976) (1997) 1.51

Quantitative evaluation of joint space width in femorotibial osteoarthritis: comparison of three radiographic views. Osteoarthritis Cartilage (1998) 1.48

Hypoadiponectinemia is associated with valvular inflammation and faster disease progression in patients with aortic stenosis. Cardiology (2011) 1.42

[Measurement of the hip joint space using automatic digital image analysis]. Rev Rhum Ed Fr (1993) 1.41

Mitral valve prolapse as a risk factor for infective endocarditis. Lancet (1989) 1.41

Phospholipase A2 activity in human osteoarthritic cartilage. J Rheumatol Suppl (1989) 1.41

Change in regional cartilage morphology and joint space width in osteoarthritis participants versus healthy controls: a multicentre study using 3.0 Tesla MRI and Lyon-Schuss radiography. Ann Rheum Dis (2010) 1.38

Reoperation for secondary hyperparathyroidism in chronic renal failure. Nephrol Dial Transplant (1991) 1.38

Assessment of the radioanatomic positioning of the osteoarthritic knee in serial radiographs: comparison of three acquisition techniques. Osteoarthritis Cartilage (2006) 1.37

Cartilage degradative enzymes in human osteoarthritis: effect of a nonsteroidal antiinflammatory drug administered orally. Semin Arthritis Rheum (1990) 1.30

OARSI-OMERACT definition of relevant radiological progression in hip/knee osteoarthritis. Osteoarthritis Cartilage (2009) 1.30

Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: a one year prospective study. Ann Rheum Dis (1998) 1.27

Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study. Osteoarthritis Cartilage (1998) 1.26

Subregional femorotibial cartilage morphology in women--comparison between healthy controls and participants with different grades of radiographic knee osteoarthritis. Osteoarthritis Cartilage (2009) 1.24

Determinants of the apoptotic response to lysosomal photodamage. Photochem Photobiol (2000) 1.19

Requirement for total hip arthroplasty: an outcome measure of hip osteoarthritis? J Rheumatol (1999) 1.17

Increased serum C-reactive protein levels by immunonephelometry in patients with rapidly destructive hip osteoarthritis. Rev Rhum Engl Ed (1998) 1.15

The cell density of human femoral head cartilage. Clin Orthop Relat Res (1977) 1.15

Early changes in lapine menisci during osteoarthritis development: Part I: cellular and matrix alterations. Osteoarthritis Cartilage (2001) 1.15

Measurement of structural progression in osteoarthritis of the hip: the Barcelona consensus group. Osteoarthritis Cartilage (2004) 1.12

Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis. Ann Rheum Dis (2003) 1.12

Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label study. Rheumatology (Oxford) (2002) 1.12

Performance of a non-fluoroscopically assisted substitute for the Lyon schuss knee radiograph: quality and reproducibility of positioning and sensitivity to joint space narrowing in osteoarthritic knees. Osteoarthritis Cartilage (2008) 1.10

Leukocyte migration test and renal allograft rejection. Transplantation (1972) 1.10

Distribution of SPARC during neovascularisation of degenerative aortic stenosis. Heart (2006) 1.09

Serum levels of YKL-40 and C reactive protein in patients with hip osteoarthritis and healthy subjects: a cross sectional study. Ann Rheum Dis (2000) 1.08

Rheumatic disorders developed after hepatitis B vaccination. Rheumatology (Oxford) (1999) 1.07

Serum levels of type IIA procollagen amino terminal propeptide (PIIANP) are decreased in patients with knee osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage (2004) 1.06

Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis. The ECHODIAH Cohort. Ann Rheum Dis (2005) 1.05

Matrix metalloproteinase-1, -3, -13 and aggrecanase-1 and -2 are differentially expressed in experimental osteoarthritis. Biochim Biophys Acta (2001) 1.05

Quantitative histological changes in osteoarthritic hip cartilage. Morphometric analysis of 29 osteoarthritic and 26 normal human femoral heads. Clin Orthop Relat Res (1974) 1.04

Diacerhein in the treatment of osteoarthritis of the hip. Arthritis Rheum (1994) 1.02

Sex differences in hip osteoarthritis: results of a longitudinal study in 508 patients. Ann Rheum Dis (2003) 1.02

Superiority of the Lyon schuss view over the standing anteroposterior view for detecting joint space narrowing, especially in the lateral tibiofemoral compartment, in early knee osteoarthritis. Ann Rheum Dis (2007) 1.01

Increased urinary type II collagen helical and C telopeptide levels are independently associated with a rapidly destructive hip osteoarthritis. Ann Rheum Dis (2006) 1.00

Early decrease of serum biomarkers of type II collagen degradation (Coll2-1) and joint inflammation (Coll2-1 NO₂ ) by hyaluronic acid intra-articular injections in patients with knee osteoarthritis: a research study part of the Biovisco study. J Orthop Res (2013) 1.00

Evaluation of the 'Lequesne's false profile' of the hip in patients with hip osteoarthritis. Osteoarthritis Cartilage (1999) 0.99

Glucosamine sulfate modulates dysregulated activities of human osteoarthritic chondrocytes in vitro. Osteoarthritis Cartilage (2000) 0.98

Antibodies to types I, II, IX, and XI collagen in the serum of patients with rheumatic diseases. Arthritis Rheum (1988) 0.97

Effect of non-steroidal anti-inflammatory drugs (NSAIDS) on glycosyltransferase activity from human osteoarthritic cartilage. Br J Rheumatol (1992) 0.97

Influence of the quality of tibial plateau alignment on the reproducibility of computer joint space measurement from Lyon schuss radiographic views of the knee in patients with knee osteoarthritis. Osteoarthritis Cartilage (2004) 0.96

Measurement of the radiological hip joint space width. An evaluation of various methods of measurement. Osteoarthritis Cartilage (2001) 0.96

Tissue inhibitor of metalloprotease-1 (TIMP-1) serum level may predict progression of hip osteoarthritis. Osteoarthritis Cartilage (2001) 0.96

Formation and phenotype of cell clusters in osteoarthritic meniscus. Arthritis Rheum (2001) 0.96

Long term effects of dichloromethylene diphosphonate in Paget's disease of bone. J Clin Endocrinol Metab (1982) 0.96

Quantitative measurement of joint space narrowing progression in hip osteoarthritis: a longitudinal retrospective study of patients treated by total hip arthroplasty. Br J Rheumatol (1998) 0.95

[Study of 6 cases of malaria acquired near Roissy-Charles-de-Gaulle in 1994. Necessary prevention measures in airports]. Bull Acad Natl Med (1995) 0.95

Intra-articular injections of hylan G-F 20 in patients with symptomatic hip osteoarthritis: an open-label, multicentre, pilot study. Clin Exp Rheumatol (2003) 0.94

Early changes in lapine menisci during osteoarthritis development: Part II: molecular alterations. Osteoarthritis Cartilage (2001) 0.94

Relation of regional articular cartilage morphometry and meniscal position by MRI to joint space width in knee radiographs. Osteoarthritis Cartilage (2009) 0.94

Differential gene expression analysis in a rabbit model of osteoarthritis induced by anterior cruciate ligament (ACL) section. Biorheology (2002) 0.94

Relevant change in radiological progression in patients with hip osteoarthritis. I. Determination using predictive validity for total hip arthroplasty. Rheumatology (Oxford) (2002) 0.93

[Intrapericardial teratomas of the newborn. Apropos of 2 cases with surgical success]. Arch Mal Coeur Vaiss (1968) 0.93

Ultrasound of the ankle. Eur J Ultrasound (2001) 0.93

Study of the effect of a glycosaminoglycan-peptide complex on the degradative enzyme activities in human osteoarthritic cartilage. Clin Rheumatol (1990) 0.92

Long-term effects of dichloromethylene diphosphonate (CI2MDP) on skeletal lesions in multiple myeloma. Metab Bone Dis Relat Res (1982) 0.92

Differences in biomarkers of type II collagen in atrophic and hypertrophic osteoarthritis of the hip: implications for the differing pathobiologies. Osteoarthritis Cartilage (2006) 0.92

Screening of degradative enzymes from articular cartilage in experimental osteoarthritis. Clin Rheumatol (1987) 0.91

Lipid-mediated inflammation and degeneration of bioprosthetic heart valves. Eur J Clin Invest (2009) 0.91

Histological cartilage changes in a rabbit model of osteoarthritis. J Rheumatol (1987) 0.91

Is there evidence to support the inclusion of viscosupplementation in the treatment paradigm for patients with hip osteoarthritis? Clin Exp Rheumatol (2005) 0.91